[ad_1]
Pfizer and Biontech are the first pharmaceutical companies to publish successful data (Dogokan Kaskinkelich / Anatolia)
“Pfizer” and “Biontech” announced that the vaccine against Covid-19 they are developing is “90% effective”, after a preliminary analysis of the results of the third phase of clinical trials, which is the last before submitting an application for license. This represents a great victory in the battle against the epidemic that has killed more than a million people and destroyed the world economy, and has changed the patterns of daily life.
The two companies said in a joint statement that “this vaccine effectiveness” was measured by comparing the number of participants who contracted the coronavirus in the group that received the vaccine and the number of infected people in another group that received a placebo vaccine. ” seven days after receiving the second dose “and 28 days after receiving it. The first dose. Pfizer and its partner, German biotechnology company Biontech, are the first two pharmaceutical companies to publish successful data from a large-scale clinical trial of a coronavirus vaccine.
The two companies said they had yet to encounter serious safety concerns and were hoping to get a U.S. permit this month to use the vaccine in emergency situations.
If they get permission, the number of doses will be limited at first and many questions remain unanswered, including how long the vaccine provides protection. However, the news provides hope that other Covid-19 vaccines, in development, may also prove effective.
“Today is a great day for science and humanity,” said Albert Burla, CEO of Pfizer.
“We have reached this critical milestone in our vaccine development program at a time when the world desperately needs it, with infection rates setting new records, hospitals nearly full and the fight against the reopening of economies.”
[ad_2]
